ResearcherYeungnam UniversityActive in the last 2 years
Jung-Ae Kim
Matched on ORCID iD 0000-0002-0824-8532; OpenAlex author ID A5101774713.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 2
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Therapeutic targeting of GSK-3β activation by the tyrosine kinase RYK in pancreatic ductal adenocarcinoma with BJ-2412, a novel sunitinib analogue. Last author DOI 10.1111/bph.70455↗
- TPH1 and 5-HT7 Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers13215305↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Prakash Chaudhary · 2 shared papers, 2021–2026
- Paper Therapeutic targeting of GSK-3β activation by the tyrosine kinase RYK in pancreatic ductal adenocarcinoma with BJ-2412,… DOI 10.1111/bph.70455↗
- Paper TPH1 and 5-HT7 Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZ… DOI 10.3390/cancers13215305↗
- Kiran Yadav · 1 shared paper, 2026
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.